Biomarkers in psychiatric disorders: status quo, impediments and facilitators.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Biological research on mental pain, social pain and other pains not primarily felt in the body: methodological systematic review.The British journal of psychiatry : the journal of mental science · 2025
   Pooled it
2. Conceptual and pragmatic clinical implications of dichotomizing psychotropics as targeting physiology-physiomodal and pathology-pathomodal.The international journal of neuropsychopharmacology · 2026
   Review
3. Bipolar II disorder: a state-of-the-art review.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
   Article
4. Future Challenges for the Diagnosis and Management of Affective Disorders: From Preclinical Evidence to Clinical Trials.Brain sciences · 2025
   Article
5. What is the relationship between exposure to environmental pollutants and severe mental disorders? A systematic review on shared biological pathways.Brain, behavior, & immunity - health · 2025
   Review
6. OBF-Psychiatric, a motor activity dataset of patients diagnosed with major depression, schizophrenia, and ADHD.Scientific data · 2025
   Article
7. Neurophysiological Markers of Emotional Stimuli Processing in Schizophrenia and Schizoaffective Disorder.Consortium psychiatricum · 2025
   Article
8. Flavins and Flavoproteins in the Neuroimmune Landscape of Stress Sensitization and Major Depressive Disorder.Journal of inflammation research · 2025
   Review
9. Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity.Frontiers in behavioral neuroscience · 2025
   Review
10. Underlying biological mechanisms of emotion dysregulation in bipolar disorder.Frontiers in psychiatry · 2025
    Review
11. Affective Temperaments and Seasonality in Patients with Mood Disorders.Neuropsychiatric disease and treatment · 2025
    Article
12. Exploring the diversity and determinants of various depression symptoms in youth: analysis based on the living environments of university students.Frontiers in psychiatry · 2025
    Article
13. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression Treatment.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024
    Article
14. Leveraging big data for causal understanding in mental health: a research framework.Frontiers in psychiatry · 2024
    Review
15. Illness-related variables and abnormalities of resting-state brain activity in schizophrenia.Frontiers in psychiatry · 2024
    Article
16. Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.Journal of psychiatry & neuroscience : JPN
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.